TY - JOUR
T1 - Incidence and mortality of thyroid cancer in 50 countries
T2 - a joinpoint regression analysis of global trends
AU - Huang, Junjie
AU - Ngai, Chun Ho
AU - Deng, Yunyang
AU - Pun, Ching Nei
AU - Lok, Veeleah
AU - Zhang, Lin
AU - Xu, Qiang
AU - Lucero-Prisno, Don Eliseo
AU - Xu, Wanghong
AU - Zheng, Zhi-Jie
AU - Elcarte, Edmar
AU - Withers, Mellissa
AU - Wong, Martin C.S.
AU - NCD Global Health Research Group
AU - Association of Pacific Rim Universities (APRU)
N1 - Funding Information:
This work was supported by Direct Grant for Research (Grant number: 2020.026), Chinese University of Hong Kong.
Publisher Copyright:
© 2023, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
PY - 2023
Y1 - 2023
N2 - Purpose: To evaluate the incidence and mortality trend of thyroid cancer, and compare its global incidence trends among different countries by age group and sex. Methods: Data on age-standardized incidence and mortality rate of thyroid cancer among 50 countries were collected from the Cancer Incidence in Five Continents Volume XI; the Surveillance, Epidemiology, and End Results Program (SEER), the National Cancer Institute; the Nordic Cancer Registries (NORDCAN), and the WHO mortality database. The Average Annual Percent Change (AAPC) of the incidence and mortality trends was calculated by joinpoint regression analysis. Results: The age-standardized incidence of thyroid cancer was 3.1 and 10.1 cases per 100,000 persons in men and women, respectively. The incidence of thyroid cancer increased in most countries among individuals irrespective of age groups, and increased in populations aged <40 years in several countries, including Korea (male: AAPC 25.3, 95% C.I. 22.3–28.4, p < 0.001; female: AAPC 18.5, 95% C.I. 16.2–20.9, p < 0.001), Poland (male: AAPC 19.1, 95% C.I. 1.4–39.7, p = 0.036; female: AAPC 13.7, 95% C.I. 7.6–20.2), and China (male: AAPC 18.6, 95% C.I. 12.1–25.5, p < 0.001; female: AAPC 13.3, 95%C.I. 11.5–15.1, p < 0.001). Conclusion: An increasing incidence of thyroid cancer was observed in younger subjects in a majority of countries, highlighting the need for more preventive strategies in this population and possible avoidance of over-diagnosis.
AB - Purpose: To evaluate the incidence and mortality trend of thyroid cancer, and compare its global incidence trends among different countries by age group and sex. Methods: Data on age-standardized incidence and mortality rate of thyroid cancer among 50 countries were collected from the Cancer Incidence in Five Continents Volume XI; the Surveillance, Epidemiology, and End Results Program (SEER), the National Cancer Institute; the Nordic Cancer Registries (NORDCAN), and the WHO mortality database. The Average Annual Percent Change (AAPC) of the incidence and mortality trends was calculated by joinpoint regression analysis. Results: The age-standardized incidence of thyroid cancer was 3.1 and 10.1 cases per 100,000 persons in men and women, respectively. The incidence of thyroid cancer increased in most countries among individuals irrespective of age groups, and increased in populations aged <40 years in several countries, including Korea (male: AAPC 25.3, 95% C.I. 22.3–28.4, p < 0.001; female: AAPC 18.5, 95% C.I. 16.2–20.9, p < 0.001), Poland (male: AAPC 19.1, 95% C.I. 1.4–39.7, p = 0.036; female: AAPC 13.7, 95% C.I. 7.6–20.2), and China (male: AAPC 18.6, 95% C.I. 12.1–25.5, p < 0.001; female: AAPC 13.3, 95%C.I. 11.5–15.1, p < 0.001). Conclusion: An increasing incidence of thyroid cancer was observed in younger subjects in a majority of countries, highlighting the need for more preventive strategies in this population and possible avoidance of over-diagnosis.
KW - Age
KW - Incidence
KW - Mortality
KW - Temporal trend
KW - Thyroid cancer
UR - https://www.scopus.com/pages/publications/85145942384
U2 - 10.1007/s12020-022-03274-7
DO - 10.1007/s12020-022-03274-7
M3 - Article
C2 - 36607509
AN - SCOPUS:85145942384
SN - 1355-008X
VL - 80
SP - 355
EP - 365
JO - Endocrine
JF - Endocrine
ER -